Table 1.

Demographic and clinical characteristics of patients in the death and survival groups

Characteristics	All patients (n = 98)	Death (n = 46)	Survival (n = 52)	p value*
Age
Mean ± SD (year)	71.1 ± 8.5	72.7 ± 8.9	69.7 ± 8.0	0.074
Range (year)	60–95	60–95	61–92
Sex
Male	65 (66.3%)	36 (78.3%)	29 (55.8%)	0.019
Female	33 (33.7%)	10 (21.7%)	23 (44.2%)
History of exposure
Familial cluster	2 (2.0%)	0	2 (3.8%)	0.179
Medical staff	1 (1.0%)	0	1 (1.9%)	0.344
Huanan market	2 (2.0%)	0	2 (3.8%)	0.179
Symptoms
Fever	78 (79.6%)	35 (76.1%)	43 (82.7%)	0.418
Cough	44 (44.9%)	25 (54.3%)	19 (36.5%)	0.077
Dyspnea	17 (17.3%)	13 (28.3%)	4 (7.7%)	0.007
Chest tightness	9 (9.2%)	7 (15.2%)	2 (3.8%)	0.052
Fatigue and poor appetite	21 (21.4%)	11 (23.9%)	10 (19.2%)	0.573
Diarrhea	11 (11.2%)	7 (15.2%)	4 (7.7%)	0.239
Rhinorrhea		0	1 (1.9%)	0.344
Comorbidities
Hypertension	46 (46.9%)	21 (45.7%)	25 (48.1%)	0.810
Type 2 diabetes	14 (14.3%)	5 (10.9%)	9 (17.3%)	0.363
Coronary heart disease	15 (15.3%)	9 (19.6%)	6 (11.5%)	0.271
COPD	7 (7.1%)	5 (10.9%)	2 (3.8%)	0.178
Postoperative lung cancer	2 (2.0%)	1 (2.2%)	1 (1.9%)	0.930
Chronic renal disease	10 (10.2%)	8 (17.4%)	2 (3.8%)	0.027
Chronic hepatitis	2 (2.0%)	2 (4.3%)	0	0.129
None	31 (31.6%)	13 (28.3%)	18 (34.6%)	0.500
Symptom onset before CT, median (IQR) (days)	7 (3.75–10)	6 (2.75–10)	8 (4–11)	0.142
Hospital stay, median (IQR) (days)	16.5 (7.75–25)	7 (3–11)	24 (19–29)	< 0.001

*Between death group and survival group

COPD, chronic obstructive pulmonary disease